• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceEXABLATE
Generic Namemr-guided focused ultrasound system
ApplicantInSightec
5 nahum heth street
tirat-hacarmet 39120
PMA NumberP150038
Date Received10/21/2015
Decision Date07/11/2016
Product Code POH 
Docket Number 16M-2183
Notice Date 07/25/2016
Advisory Committee Neurology
Clinical TrialsNCT01827904
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
Approval for the ExAblate Model 4000 Type 1.0 System (ExAblate Neuro). This device is indicated for use in the unilateral Thalamotomy treatment of idiopathic Essential Tremor patients with medication-refractory tremor. Patients must be at least age 22. The designated area in the brain responsible for the movement disorder symptoms (ventralis intermedius) must be identified and accessible for targeted thermal ablation by the ExAblate device.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S003  S001 S002 S004 S005 S006 S007 S008 S009 S010 S011 
S012 S013 S014 S018 S019 S020 S021 S023 S024 
-
-